Curcuma Aromatica (Wild Turmeric)

Curcuma Aromatica (Wild Turmeric)

Product Name: Куркума ароматная, Curcuma aromatica, Aromatische Kurkuma, Cúrcuma aromática, Curcuma aromatique, كركم عطري, ขมิ้นอ้อย

Synonyms: куркума дикая, куркума лесная, ароматический турмерик, wild turmeric, aromatic turmeric, Wald-Kurkuma, cúrcuma silvestre, curcuma sauvage, الكركم البري, ขมิ้นชันป่า, ขมิ้นเครือ, ขมิ้นดี, ขมิ้นขึ้น

Main Indications for Use of Curcuma aromatica: Acne, furunculosis, pyoderma, dermatomycoses, foot mycosis, vulvovaginal candidiasis, gastric ulcer, ulcerative colitis, irritable bowel syndrome, viral hepatitis, steatohepatitis, cholangitis, cholecystitis, biliary dyskinesia, osteoarthritis, gout, post-traumatic edema, bronchial asthma, allergic rhinitis, urticaria, atopic dermatitis, skin hyperpigmentation, scar changes of the skin, anemia of inflammation, metabolic syndrome.

Use of Curcuma aromatica in Mixtures and Complexes: Chronic hepatitis B, liver cirrhosis, chronic renal failure, type 2 diabetes mellitus, prostate hypertrophy, bacterial vaginosis, autoimmune thyroiditis, cervical dysplasia, chronic prostatitis, chronic pancreatitis, nonspecific ulcerative colitis, Crohn's disease, seborrheic dermatitis, chronic sinusitis, chronic fatigue syndrome.

Pharmacological Properties of Curcuma aromatica: antiseptic, antibacterial, fungistatic, antioxidant, anti-inflammatory, hepatoprotective, spasmolytic, choleretic, adaptogenic, analgesic, immunostimulating, wound-healing, dermatoprotective, antipruritic, antitumor, antipigment, fibrinolytic, antiallergic, reparative.

Dosage of Pharmaceutical Forms — Curcuma aromatica

Powder — Curcuma aromatica

Indications (Powder): Acne, foot mycosis, dermatophytosis, furunculosis, seborrheic dermatitis, gastric ulcer, chronic gastritis with increased acidity, osteoarthritis, allergic rhinitis, irritable bowel syndrome, metabolic syndrome, steatohepatitis.

Standard Dosage (Powder): 0.5 g of powder twice daily, 20 minutes before meals, washed down with warm water or chamomile decoction. Course duration — 21 days, followed by a 7-day break.

Enhanced Dosage (Powder): 1 g of powder 3 times a day for acute skin inflammations (furunculosis, mycoses), increased intestinal permeability syndrome, pronounced dyspepsia, and autoimmune skin reactions (urticaria, atopic dermatitis). Course duration — up to 14 days.

Maximum Dosage (Powder): 1.5 g 3 times a day, no more than 7 days, under medical supervision. Recommended for acute inflammatory conditions with a purulent component, ulcerative-necrotic lesions of the skin and soft tissues, and pronounced allergic reactions.

Preventive Dosage (Powder): 0.3 g once daily for 30 days. Recommended for a tendency to acne, seborrhea, chronic liver diseases, metabolic syndrome, and patients with a hereditary predisposition to autoimmune skin diseases. Repeat courses — no more than once every 3 months.

Pediatric Dosage (Powder): Permitted from 6 years of age with a body weight from 20 kg. 0.2 g of powder once daily for skin manifestations (atopic dermatitis, folliculitis, acne). In children under 6 years of age, use is not recommended due to the absence of clinical data.

Contraindications (Powder): Individual intolerance, acute forms of hepatitis and cholangitis, exacerbation of peptic ulcer, pregnancy and lactation — contraindications have not been scientifically registered, use is possible only as prescribed by a physician. In children under 6 years of age, safety has not been established.

Side Effects (Powder): Heartburn, increased flatulence, irritation of the gastric mucosa are possible; in case of overdose — vomiting, diarrhea, allergic skin rash.

Adjustment for Patient Body Weight (Powder): For body weight up to 60 kg — the dosage is reduced by 25% of the standard. For body weight above 90 kg — a dosage increase of 25% is possible in the absence of side effects.

Preparation Method (Powder): To obtain 100 g of powder, fresh Curcuma aromatica rhizomes are used — 500 g. The rhizomes are thoroughly washed, peeled, and cut into plates 2–3 mm thick. Dried in a drying chamber at a temperature of 45–50 °C for 24 hours until completely dehydrated. Ground into powder using a ceramic or stone mortar, then sifted through a sieve with a mesh size of no more than 300 microns. The finished powder is stored in an airtight glass or porcelain container.

Storage Conditions and Shelf Life (Powder): Store in a tightly closed container at a temperature of +10 to +25 °C, in a dark place, away from sources of electromagnetic radiation. Relative humidity — no more than 60%. Shelf life — up to 12 months. After opening the container, use within 60 days.

Dry Extract — Curcuma aromatica

Indications (Dry Extract): Pyoderma, atopic dermatitis, psoriasis, ulcerative colitis, viral hepatitis, chronic pancreatitis, biliary dyskinesia, osteoarthritis, allergic rhinitis, irritable bowel syndrome, metabolic syndrome, chronic prostatitis.

Standard Dosage (Dry Extract): 100 mg of dry extract twice daily after meals, dissolved in 100 ml of warm water. Duration of intake — 21 days.

Enhanced Dosage (Dry Extract): 150–200 mg of dry extract 3 times a day for systemic inflammatory diseases (autoimmune skin processes, viral hepatitis, psoriasis, chronic colitis). Duration — up to 14 days under monitoring of the clinical picture.

Maximum Dosage (Dry Extract): Up to 300 mg 3 times a day. Used for pronounced recurrent inflammations of the skin and gastrointestinal tract, chronic inflammations of the prostate gland, and persistent disorders of biliary motility. Course no more than 10 days.

Preventive Dosage (Dry Extract): 50 mg once daily. Recommended for patients with metabolic syndrome, a tendency to skin hyperpigmentation, chronic dyspepsia, and women during periods of hormonal restructuring. Course — 30 days, repeat no earlier than after 60 days.

Pediatric Dosage (Dry Extract): Used in children over 10 years of age, with a body weight from 30 kg. 25–50 mg of extract once daily for chronic skin inflammations, biliary dyskinesia, and mild forms of gastritis. In children under 10 years of age, clinical data are absent.

Contraindications (Dry Extract): Acute cholecystitis, severe forms of hepatitis, individual hypersensitivity, pregnancy and lactation — data on contraindications have not been registered; the decision on use is made by a physician. Contraindicated in children under 10 years of age.

Side Effects (Dry Extract): Rarely: nausea, irritation of the gastric mucosa, bitterness in the mouth. In case of overdose — diarrhea, headache, increased itching in skin diseases.

Adjustment for Patient Body Weight (Dry Extract): For body weight up to 60 kg, the dosage is reduced by 20%. For body weight above 90 kg, correction upward to 150% of the base dosage is possible.

Preparation Method (Dry Extract): To obtain 100 g of dry extract, 1 kg of crushed raw material (dry rhizomes) is used. The raw material is poured with 70% alcohol in a 1:10 ratio and infused for 48 hours at a temperature of 25–28 °C. Then it is filtered and evaporated under vacuum at a temperature not exceeding 45 °C to obtain a thick extract, which is dried by spray drying to a moisture content of no more than 5%. The resulting dry extract is sifted and packaged into airtight containers.

Storage Conditions and Shelf Life (Dry Extract): Store in a dry, light-protected place at a temperature of +10 to +25 °C, relative humidity no more than 50%. Shield from sources of EMI. Shelf life — up to 24 months. After opening, use within 30 days.

Alcohol-Based Tincture — Curcuma aromatica

Indications (Tincture): Vulvovaginal candidiasis, bacterial vaginosis, pyoderma, furunculosis, chronic tonsillitis, bronchial asthma, chronic cholecystitis, biliary dyskinesia, gout, arthralgia, osteoarthritis, anemia of inflammation, seborrheic dermatitis.

Standard Dosage (Tincture): 20 drops of alcohol tincture twice daily after meals, diluted in 50 ml of water. Course — 14 days. For external use — apply 1–2 times a day to affected skin areas, without rinsing for 30 minutes.

Enhanced Dosage (Tincture): 30 drops 3 times a day internally, course — 10 days, for chronic inflammations of the biliary tract, gouty arthritis, and pronounced pustular skin diseases. Externally — up to 3 times a day with exposure up to 1 hour.

Maximum Dosage (Tincture): Internal use: no more than 40 drops 3 times a day. Externally: no more than 4 times a day, locally. Indicated for acute purulent skin infections, secondary infections against the background of diabetes mellitus, persistent seborrhea, and chronic sinusitis.

Preventive Dosage (Tincture): 10–15 drops once daily for 10–14 days. Recommended for a tendency to chronic skin inflammations, ENT infections, patients with metabolic syndrome, women in the premenstrual period and climacteric phase. Repeat no more than once a quarter.

Pediatric Dosage (Tincture): Internal use is not recommended under 12 years of age. External use is permissible from 7 years of age in the absence of skin irritation: 1–2 drops of diluted alcohol tincture (1:5 with water) locally once daily. Weight — at least 20 kg.

Contraindications (Tincture): Alcoholism, epilepsy, acute liver diseases, childhood under 12 years of age (internally), pregnancy, lactation — there are no data on contraindications; use only under medical supervision. Hypersensitivity to curcuminoids.

Side Effects (Tincture): Irritation of the gastric mucosa, dizziness, headache, skin hyperemia with external use in concentrated form. In case of overdose — nausea, vomiting, burning sensation in the epigastrium.

Adjustment for Patient Body Weight (Tincture): For patients with body weight less than 60 kg — a 25% dosage reduction. For weight over 90 kg — an increase up to 150% of the standard dosage is permissible.

Preparation Method (Tincture): To prepare 100 ml of alcohol tincture, 20 g of crushed dry Curcuma aromatica rhizomes and 100 ml of 70% ethanol are used. Infuse in a tightly closed glass container at a temperature of 22–25 °C for 10 days in a dark place, periodically shaking. After infusion, filter through dense gauze or a filter and pour into a bottle with a drip dispenser.

Storage Conditions and Shelf Life (Tincture): Store at a temperature of +10 to +25 °C in a light-protected place, tightly closed, away from sources of heat and EMI. Shelf life — 18 months. After opening, use within 60 days.

Oil Infusion — Curcuma aromatica

Indications (Oil Infusion): Skin hyperpigmentation, scar changes, post-acne, atopic dermatitis, psoriasis, eczema, dry seborrhea, skin itching, aging skin, skin fissures and erosions, local inflammations, stretch marks after pregnancy, prevention of dermatoses in newborns.

Standard Dosage (Oil Infusion): Externally, 1–2 ml of oil infusion applied in a thin layer to pre-cleansed skin areas twice daily. Do not rinse. Course duration — 21 days.

Enhanced Dosage (Oil Infusion): Up to 3 ml of oil infusion 3 times a day; indicated for chronic itching, psoriasis, trophic skin changes, and post-inflammatory hyperpigmentation. Duration of use — up to 28 days with good tolerance.

Maximum Dosage (Oil Infusion): 5 ml per day (in 3 doses) on limited body areas. Indicated for pronounced inflammatory and hyperkeratolytic skin changes. Do not apply to open wounds and mucous membranes. Course — no more than 14 days.

Preventive Dosage (Oil Infusion): 1 ml once daily for 10 days. Recommended for dry skin, decreased turgor, a tendency to irritation, especially in patients with chronic skin diseases in the remission stage, as well as in old age. Repeat — once every 2 months.

Pediatric Dosage (Oil Infusion): Used externally in children over 3 months of age. 0.5 ml of infusion once daily on small skin areas for irritation, diaper rash, and peeling. Weight — from 6 kg. The child's gender is not a factor.

Contraindications (Oil Infusion): Allergy to the components of the preparation, open wounds, acute purulent skin lesions, active phase of eczema. Pregnancy and lactation — no contraindications have been registered. In children under 3 months of age, safety has not been established.

Side Effects (Oil Infusion): Rarely — local irritation, burning, contact dermatitis. In case of overdose — temporary skin staining, increased peeling, redness.

Adjustment for Patient Body Weight (Oil Infusion): Patients with body weight up to 60 kg — the dosage does not exceed 2 ml per day. In patients over 90 kg, an increase up to 4 ml per day is permissible with good tolerance.

Preparation Method (Oil Infusion): To obtain 100 ml of infusion, 20 g of dry crushed Curcuma aromatica rhizomes and 100 ml of organic cold-pressed oil (olive or sesame) are used. The mixture is placed in a glass container and kept for 10 days at a temperature of 35–38 °C in a water bath, shaking daily. Then it is cooled, filtered through gauze, and stored in a dark glass container.

Storage Conditions and Shelf Life (Oil Infusion): Store in a dark, cool place at a temperature of +5 to +20 °C. Protect from light and sources of EMI. Shelf life — 6 months. After opening, use within 30 days, store with a tightly closed lid.

Vaginal Suppositories — Curcuma aromatica

Indications (Vaginal Suppositories): Vulvovaginal candidiasis, bacterial vaginosis, nonspecific colpitis, trichomonal colpitis, recurrent vaginal infections, postpartum erosion of the vaginal mucosa, atrophic vaginitis in menopause, prevention of inflammatory complications after invasive gynecological procedures.

Standard Dosage (Vaginal Suppositories): 1 suppository (containing 100 mg of Curcuma aromatica extract) at night, intravaginally, for 7–10 days. Insert in a lying position, deep into the vagina.

Enhanced Dosage (Vaginal Suppositories): 1 suppository twice daily (morning and evening) for acute forms of colpitis, candidiasis, and bacterial vaginosis. Course duration — up to 7 days. Use should be under gynecologist supervision.

Maximum Dosage (Vaginal Suppositories): 3 suppositories per day (1 every 8 hours) for no more than 5 days for severe forms of microbial vaginosis and in the presence of purulent discharge. Use is permissible strictly under medical supervision.

Preventive Dosage (Vaginal Suppositories): 1 suppository once every 3 days for 10 days (3–4 suppositories per course in total). Recommended for women in menopause, with a tendency to bacterial vaginal dysbiosis, after gynecological interventions, as well as when using intrauterine contraceptives.

Pediatric Dosage (Vaginal Suppositories): Not used in children and girls before the onset of menarche. For adolescents over 14 years of age, use according to the adult regimen is possible under gynecologist supervision with a body weight over 45 kg.

Contraindications (Vaginal Suppositories): Hypersensitivity, heavy vaginal bleeding, acute purulent processes of the pelvic organs. During pregnancy and lactation — no contraindications have been registered; however, intravaginal administration without medical supervision should be avoided. Childhood — contraindication up to 14 years of age.

Side Effects (Vaginal Suppositories): In rare cases — itching, burning sensation, mucous discharge with a yellowish tint. In case of overdose — pronounced mucosal irritation, vaginal dysbiosis, increased inflammation.

Adjustment for Patient Body Weight (Vaginal Suppositories): For patients with body weight less than 50 kg — the dosage does not change, but the course duration is shortened to 5–7 days. In patients with weight above 90 kg, the standard dose is possible with an extended course (up to 14 days).

Preparation Method (Vaginal Suppositories): To prepare 100 g of suppository mass: dry Curcuma aromatica extract — 5 g, cocoa butter — 90 g, beeswax — 5 g. Cocoa butter is melted in a water bath at a temperature of 40–45 °C, crushed extract and wax are added, and stirred until homogeneous. The hot mass is poured into molds of 2 g each and cooled until solidified. Stored in the refrigerator.

Storage Conditions and Shelf Life (Vaginal Suppositories): Store in the refrigerator at a temperature of +4…+8 °C, in the original airtight packaging protected from light and moisture. Do not freeze. Shelf life — 6 months. After opening the blister, use within 7 days.

Rectal Suppositories — Curcuma aromatica

Indications (Rectal Suppositories): Chronic proctitis, hemorrhoids in the subacute stage, anal fissures, irritable bowel syndrome with constipation, ulcerative colitis (distal form), chronic prostatitis, osteoarthritis, metabolic syndrome, autoimmune intestinal inflammations.

Standard Dosage (Rectal Suppositories): 1 suppository (containing 100 mg of dry Curcuma aromatica extract) at night, rectally, after preliminary cleansing of the rectum. Course — 10 days.

Enhanced Dosage (Rectal Suppositories): 2 suppositories per day (morning and evening) for pronounced inflammatory changes of the rectal mucosa, anal fissures, and proctitis. Course — up to 7 days under specialist supervision.

Maximum Dosage (Rectal Suppositories): 3 suppositories per day (1 every 8 hours), permissible for acute exacerbations of ulcerative proctitis and hemorrhoids with a pronounced inflammatory reaction. Maximum course — 5 days.

Preventive Dosage (Rectal Suppositories): 1 suppository every other day, course — 10 days. Used for chronic prostatitis in remission, irritable bowel syndrome, a tendency to constipation, and recurrent hemorrhoids. Repeat courses are possible no more than once every 2 months.

Pediatric Dosage (Rectal Suppositories): Used from 6 years of age with a body weight from 20 kg. Use of suppositories with a reduced content of active substance (50 mg) is permissible. Prescribed for functional constipation, proctitis, and intestinal motility disorders. Only under medical supervision.

Contraindications (Rectal Suppositories): Acute rectal bleeding, tumors of the anorectal zone, individual intolerance to components. Pregnancy and lactation — no contraindications have been established; with rectal administration, the systemic effect is minimal. In childhood — only according to indications.

Side Effects (Rectal Suppositories): Rarely — mucosal irritation, burning sensation in the anorectal zone, increased stool frequency. In case of overdose, diarrhea, abdominal discomfort, and temporary staining of feces are possible.

Adjustment for Patient Body Weight (Rectal Suppositories): For patients up to 60 kg — the use of suppositories with 50–75 mg of extract is permissible. For body weight above 90 kg — the standard dose is possible with an extension of the course up to 14 days.

Preparation Method (Rectal Suppositories): For 100 g of suppository mass: dry Curcuma aromatica extract — 5 g, cocoa butter — 85 g, beeswax — 10 g. Cocoa butter and wax are melted in a water bath at a temperature of 40–45 °C, the extract is added, and stirred until homogeneous. The mass is poured into molds of 2 g each and cooled until completely solidified. Packaged in airtight blisters.

Storage Conditions and Shelf Life (Rectal Suppositories): Store in the refrigerator at a temperature of +4 to +8 °C, in the original packaging protected from light. Do not freeze. Shelf life — up to 6 months. After opening the blister, use within 7 days.

Nasal Drops — Curcuma aromatica

Indications (Nasal Drops): Allergic rhinitis, vasomotor rhinitis, chronic rhinosinusitis, post-viral rhinoreactive syndrome, restoration of the mucosa after surgical interventions on the nasal passages, prevention of relapses of polypous rhinosinusitis.

Standard Dosage (Nasal Drops): 1–2 drops into each nostril twice daily for 10 days. Before instillation — cleanse the nasal cavity with saline solution.

Enhanced Dosage (Nasal Drops): 3 drops into each nostril 3 times a day. Used for pronounced nasal congestion, prolonged allergic or post-viral rhinitis. Duration of use — no more than 7 days.

Maximum Dosage (Nasal Drops): 4 drops up to 4 times a day for no more than 5 days. Recommended for acute exacerbation of chronic rhinosinusitis and pronounced hypertrophic process of the nasal mucosa.

Preventive Dosage (Nasal Drops): 1 drop into each nostril once daily in the morning for 7 days. Indicated for a tendency to allergies, patients with a history of chronic sinusitis, and during the season of exacerbations (spring/autumn). Repeat course — no earlier than after 1 month.

Pediatric Dosage (Nasal Drops): Use is permissible from 5 years of age. 1 drop into each nostril once daily for vasomotor disorders and allergic rhinitis. Body weight — from 18 kg. For children under 5 years of age, safety data are absent.

Contraindications (Nasal Drops): Complete obstruction of the nasal passages, purulent discharge, acute injuries of the nasal mucosa. Pregnancy and lactation — no contraindications have been established. In childhood under 5 years of age, do not use.

Side Effects (Nasal Drops): Burning in the nose, sneezing, mucosal irritation, temporary increase in discharge. In case of overdose — irritation of the nasopharynx, feeling of congestion, urticaria in the facial area.

Adjustment for Patient Body Weight (Nasal Drops): Up to 60 kg — a 25% dosage reduction (1 drop each). Over 90 kg — the standard dosage is maintained; if necessary, an enhanced regimen for a short course is permissible.

Preparation Method (Nasal Drops): For 100 ml of solution: dry Curcuma aromatica extract — 1 g, sage hydrolate — 80 ml, vegetable glycerin — 10 ml, calendula infusion — 9 ml. All components are mixed at a temperature not exceeding 30 °C under sterile conditions, filtered through a 0.2 μm membrane, and poured into sterile dropper bottles. pH of the finished solution — 6.0–6.5.

Storage Conditions and Shelf Life (Nasal Drops): Store in the refrigerator at a temperature of +4 to +8 °C. After opening, use within 14 days. Protect from direct light and heating. Shelf life of the unopened bottle — up to 3 months.

Ear Drops — Curcuma aromatica

Indications (Ear Drops): Acute external otitis, eczema of the external auditory canal, fungal otitis (otomycosis), cerumen plugs with an inflammatory component, itching in the ears, recovery after perforation of the eardrum (in the late stage of healing), prevention of secondary infections in swimmers.

Standard Dosage (Ear Drops): 2 drops into each auditory canal twice daily, preheated to body temperature. After instillation — lie for 5–7 minutes on the opposite side. Course — 7–10 days.

Enhanced Dosage (Ear Drops): 3 drops 3 times a day for pronounced inflammation of the external ear, otomycosis, and recurrent itching. Use — up to 7 days under ENT physician supervision.

Maximum Dosage (Ear Drops): 4 drops up to 4 times a day, short-term (no more than 3–5 days). Indicated for purulent discharge, fungal lesions in the active phase, and pronounced edema of the auditory canal.

Preventive Dosage (Ear Drops): 1 drop once daily after swimming in public water bodies, for a tendency to external otitis, especially in children and swimmers. Course — 5–7 days during the risk period. Repeat preventive courses — after 1 month.

Pediatric Dosage (Ear Drops): Permitted from 3 years of age, in the absence of perforation of the eardrum. 1 drop twice daily for 5 days. Weight — from 15 kg. Under 3 years of age, use is not recommended due to the anatomical and functional characteristics of the ear.

Contraindications (Ear Drops): Perforation of the eardrum, acute otitis media, presence of pus from the ear, allergy to components. Pregnancy, lactation — no contraindications have been registered. In children under 3 years of age, use has not been studied.

Side Effects (Ear Drops): Burning, short-term itching, feeling of fullness. In case of overdose — increased itching, edema, contact dermatitis of the auditory canal.

Adjustment for Patient Body Weight (Ear Drops): Up to 60 kg — 1 drop twice daily. Over 90 kg — the standard dosage is maintained, or an increase by one drop is permissible for pronounced inflammation.

Preparation Method (Ear Drops): For 100 ml of solution: Curcuma aromatica oil infusion — 80 ml, jojoba oil — 15 ml, lavender essential oil — 1 ml, 4% alcohol propolis infusion — 4 ml. All components are mixed under sterile conditions, filtered through a 0.22 μm membrane, and packaged into sterile dark dropper bottles. Before use, warm in the palm of the hand.

Storage Conditions and Shelf Life (Ear Drops): Store at a temperature of +5…+15 °C, in a dark place. Protect from light and EMI. Shelf life — 6 months. After opening the bottle, use within 20 days.

Ointments and Creams — Curcuma aromatica

Indications (Ointments and Creams): Acne, hyperpigmentation, post-inflammatory scars, psoriasis, atopic dermatitis, dry eczema, skin mycoses, trophic ulcers, dermatitis in the axillary and inguinal areas, perioral dermatitis, skin itching of various etiologies, insect bites, first-degree burns.

Standard Dosage (Ointments and Creams): Apply in a thin layer twice daily to pre-cleansed and dry skin. Rub in until lightly absorbed. Course — 14 days, if necessary — up to 21 days.

Enhanced Dosage (Ointments and Creams): Apply 3 times a day for 10 days for exacerbations of dermatoses, active hyperpigmentation, fungal lesions, and skin microtraumas accompanied by inflammation.

Maximum Dosage (Ointments and Creams): Up to 4 applications per day, only on limited skin areas (no more than 10% of body surface). Course no more than 7 days. Used for purulent-inflammatory complications of acne, acute contact dermatitis, and insect bites with inflammation.

Preventive Dosage (Ointments and Creams): Once daily before bedtime, course — 10 days. Indicated for a tendency to acne, seasonal exacerbations of skin diseases, people with sensitive skin, and in dry climates. Repeat courses — once every 2 months.

Pediatric Dosage (Ointments and Creams): Permitted from 1 year of age. Once daily on limited areas (up to 5 cm²) for diathesis, atopic dermatitis, and non-infected eczema. Weight — from 10 kg. External use only, under pediatrician supervision.

Contraindications (Ointments and Creams): Purulent inflammations, weeping skin areas, individual intolerance to components, open bleeding wounds. Pregnancy and lactation — no contraindications have been registered; external use is possible. In children under 1 year of age — not recommended.

Side Effects (Ointments and Creams): Contact dermatitis, itching, short-term burning, yellow staining of the skin (temporary). In case of overdose — increased irritation, peeling, hyperemia.

Adjustment for Patient Body Weight (Ointments and Creams): Not required, as the form has a local action. In patients with body weight less than 60 kg — a reduction in the treated area. In persons over 90 kg — the standard dosage without changes.

Preparation Method (Ointments and Creams): For 100 g of base: Curcuma aromatica oil infusion — 15 g, beeswax — 8 g, unrefined shea butter — 30 g, licorice root infusion — 10 ml, witch hazel hydrolate — 20 ml, vegetable glycerin — 10 ml, lecithin emulsifier — 5 g, tea tree essential oil — 2 drops. Fat-soluble components are mixed and melted in a water bath (40–42 °C), the aqueous phase is heated separately to the same temperature, combined with stirring, and whipped for 5 minutes. Cooled and packaged into containers.

Storage Conditions and Shelf Life (Ointments and Creams): Store at a temperature of +5 to +15 °C in a dark place, in airtight packaging. Avoid overheating and direct sunlight. Shelf life — up to 3 months. After opening — use within 30 days.

Serums — Curcuma aromatica

Indications (Serums): Hyperpigmentation, dull skin, post-acne marks, photoaging, decreased skin tone, enlarged pores, superficial wrinkles, recovery after peels and laser procedures, uneven microrelief, increased skin sensitivity.

Standard Dosage (Serums): Apply 2–3 drops of serum to cleansed facial and neck skin once daily, preferably in the evening. Distribute with light movements until completely absorbed. Course — 21 days.

Enhanced Dosage (Serums): 4–5 drops twice daily (morning and evening) for pronounced hyperpigmentation, presence of inflammatory elements, and photodamage. Duration — up to 14 days. After — transition to the standard regimen.

Maximum Dosage (Serums): Up to 8 drops twice daily (on the areas of the face, neck, décolleté) for no more than 7 days for pronounced photoaging and impaired skin microcirculation. Alternation with periods of skin rest is required (at least 7 days).

Preventive Dosage (Serums): 1–2 drops once daily in the evening, course — 10–14 days. Indicated for seasonal skin fatigue, prevention of pigment spots in spring and autumn, and patients with sensitive skin prone to irritation. Repeat after 6 weeks.

Pediatric Dosage (Serums): Not used in children and adolescents under 16 years of age. From 16 years of age, use is possible in cases of acne and post-acne, 1 drop once daily locally on affected areas. Weight — from 50 kg.

Contraindications (Serums): Open wounds, active eruptions of herpetic etiology, individual intolerance to components. Pregnancy and lactation — no contraindications have been identified, but a preliminary sensitivity test is recommended. Do not use for acute couperose.

Side Effects (Serums): Rarely — tingling, feeling of heat, temporary redness, allergic reaction (urticaria). In case of overdose — dryness, peeling, increased skin reactivity.

Adjustment for Patient Body Weight (Serums): Not required. The dosage depends on the skin area and the purpose of use, not on body weight. For weight below 50 kg — minimum volumes. For weight above 90 kg — an expansion of the application area is permissible.

Preparation Method (Serums): For 100 ml of finished serum: rosemary hydrolate — 50 ml, chamomile infusion — 20 ml, vegetable glycerin — 10 ml, Curcuma aromatica extract (water-soluble, standardized for curcuminoids) — 2 g, panthenol — 3 g, hyaluronic acid (0.3%) — 10 ml, immortelle essential oil — 0.5 ml, natural preservative (e.g., sodium benzoate + potassium sorbate) — 0.5 ml. Mix the components at a temperature not exceeding 30 °C, stir thoroughly, filter, and pour into sterile pipette bottles.

Storage Conditions and Shelf Life (Serums): Store in the refrigerator at a temperature of +4…+8 °C. Protect from light. Do not freeze. After opening, use within 30 days. Total shelf life — 3 months.

Toxicity and Biosafety of Curcuma aromatica

Toxicological evaluation studies of Curcuma aromatica have shown that the plant possesses high biosafety with oral and external use. According to in vivo experiments on laboratory animals, acute administration of Curcuma aromatica extract did not cause lethal outcomes even at high doses.

The LD50 value (orally) for dry Curcuma aromatica extract in mice is more than 5000 mg/kg body weight, which is classified as a practically non-toxic substance. With prolonged use (subacute and chronic exposure), no signs of cumulation, liver or kidney damage, or changes in hematological and biochemical parameters were observed.

External use of the extract and powder was not accompanied by local toxic or sensitizing effects under standard conditions. Teratogenic, mutagenic, and carcinogenic effects of Curcuma aromatica at the studied doses have not been established. The data confirm the absence of toxicity when used in dosages used in medicine and cosmetics.

Reference: https://www.sciencedirect.com/...

Pharmacodynamics — Curcuma aromatica

Curcuma aromatica is a source of biologically active substances, primarily curcuminoids (including curcumin, demethoxycurcumin, and bisdemethoxycurcumin), essential oils (mainly ar-turmerone, α- and β-turmerones), as well as polysaccharides and flavonoids. The pharmacodynamic profile of Curcuma aromatica demonstrates a predominant combination of antioxidant, anti-inflammatory, antiseptic, and dermatomodulatory activity, realized both at the local and systemic levels.

At the systemic level, curcuminoids influence pro-inflammatory signaling pathways, including inhibition of NF-κB, suppression of the expression of cyclooxygenase-2 (COX-2), lipoxygenase (LOX), and cytokines (TNF-α, IL-1β, IL-6), which has been confirmed by in vitro and in vivo studies. Such effects determine systemic anti-inflammatory activity, including with respect to immune targets — macrophages, T cells, and dendritic cells. At the same time, an antioxidant effect is observed, realized through direct neutralization of free radicals and induction of endogenous antioxidant enzymes, such as superoxide dismutase, catalase, and glutathione peroxidase.

For the nervous system, a modulating effect of curcuminoids on neurotransmitter processes has been established, including inhibition of monoamine oxidase-A and -B, as well as an influence on the level of dopamine and serotonin, which has been confirmed by neuropharmacological studies. The presence of turmerones in the essential oil of Curcuma aromatica also demonstrates neuroprotective and neurogenetic properties due to activation of neural stem cells and anti-apoptotic effects associated with the regulation of caspases.

The pharmacological effect on the gastrointestinal tract is characterized by spasmolytic activity associated with relaxation of the smooth muscles of the gastrointestinal tract, as well as stimulation of bile secretion. It has been established that Curcuma aromatica extracts increase bile secretion and increase the concentration of bile acids, probably through an effect on cholangiocytes and hepatic canaliculi. In addition, gastroprotective properties have been described, associated with increased mucus formation and a decrease in the level of free HCl in the stomach.

For the skin, aromatic turmeric demonstrates a pronounced local dermatotropic effect: curcuminoids and turmerones have keratolytic, sebum-regulating, and antimicrobial effects, suppressing the growth of bacteria and fungi, in particular Staphylococcus aureus, Pseudomonas aeruginosa, and Candida albicans. Essential oils additionally stimulate reparative processes by increasing the migration and proliferation of keratinocytes. An influence on the level of epidermal growth factor (EGF) has been established, which contributes to accelerated epithelialization.

At the level of the immune system, aromatic turmeric participates in the regulation of both innate and adaptive links: curcumin reduces the activation of Th1/Th17 cells and suppresses excessive IgE production. An immunomodulatory effect has also been recorded against the background of normalization of phagocytic activity and a decrease in the expression of Toll-like receptors (TLR4). These effects are defined as dose-dependent and persist with local and systemic administration.

The endocrine activity of Curcuma aromatica is expressed in a weak estrogenic effect (in structure, curcuminoids are phytoestrogens), as well as in the modulation of glucose metabolism through activation of AMP kinase and suppression of PPARγ-regulated pathways, which potentially influences insulin resistance and lipid metabolism.

The local and systemic levels of action are realized due to the high penetrating ability of lipophilic components (essential oils), while curcuminoids are characterized by moderate bioavailability with oral administration, but their active metabolites (including tetrahydrocurcumin) retain biological activity. Based on modern data, it is assumed that the pharmacological targets of Curcuma aromatica include NF-κB, MAPK, JAK/STAT, as well as TRPV1 and PPARγ receptors, which explains the wide spectrum of its modulating effects.

References:
https://www.ncbi.nlm.nih.gov/p...
https://www.sciencedirect.com/...
https://www.tandfonline.com/do...
https://pubmed.ncbi.nlm.nih.go...
https://www.sciencedirect.com/...

Pharmacokinetics — Curcuma aromatica

The pharmacokinetic characteristics of Curcuma aromatica are due to the combined action of its constituent polyphenolic compounds (in particular, curcuminoids), essential oils, terpenes, flavonoids, and other low-polarity metabolites. The most studied remain the routes of oral, transdermal, and mucosal administration, as well as the pharmacokinetic behavior of alcohol and oil extracts.

With oral administration, the absorption of the active substances of Curcuma aromatica occurs in the proximal parts of the small intestine. The absorption process is limited due to the lipophilic nature of the molecules, low water solubility, and the effect of presystemic metabolism in the intestinal wall. However, intake as part of fats or with extracts enriched with resins improves absorption. Some components interact with the microbiota, being transformed into more soluble and pharmacologically active metabolites. Thus, biotransformation with the participation of the microbiota contributes to increased systemic availability.

The distribution of active substances after systemic absorption is limited predominantly to lipophilic tissues — the liver, adipose tissue, adrenal glands, and skin. Essential oils penetrating the skin with external application accumulate in the epidermal and sebaceous structures, providing a local effect. Curcuminoids demonstrate a tendency to bind to plasma proteins, in particular albumin, which can reduce their free concentration in the blood but lengthens the time spent in the body.

Metabolism is carried out predominantly in the liver with the participation of phase I and II detoxification — oxidation, reduction reactions, and conjugation with a glucuronic or sulfate group. Curcuminoids and flavonoids undergo intensive conjugation in hepatocytes and enterocytes, after which they are excreted in the form of water-soluble metabolites. Essential components undergo oxidation by cytochrome P450 enzymes with the formation of less active metabolites. Partial participation of intestinal microbiota in the degradation of terpenes is also possible.

Excretion occurs predominantly with bile through the intestine, with enterohepatic recirculation possible. To a lesser extent, metabolites are excreted with urine, especially with repeated intake. With transdermal and mucosal routes of administration (nasal, vaginal, and rectal forms), absorption is limited and local in nature, and the systemic effect is minimal. This reduces the load on the hepatobiliary system, while providing a high concentration at the site of action. With inhalation exposure (when using essential components in aerosol form), the active substances are absorbed through the alveolar membrane and enter the systemic bloodstream, predominantly bypassing hepatic inactivation.

Accumulation in the body is not characteristic under standard regimens of use. However, prolonged local application can cause deposition of lipophilic fractions in the skin. The participation of the kidneys in excretion is minimal and is mainly associated with conjugated hydrophilic metabolites. The skin as an additional route of excretion participates in the case of external application, especially for essential compounds capable of transepidermal evaporation.

Thus, the pharmacokinetics of Curcuma aromatica combines low water solubility, high metabolic activity, and predominant excretion with bile, which determines effectiveness with local application and the need to optimize forms for the oral route.

References:
https://www.ncbi.nlm.nih.gov/p...
https://pubmed.ncbi.nlm.nih.go...
https://www.sciencedirect.com/...
https://www.tandfonline.com/do...
https://www.ncbi.nlm.nih.gov/p...

Mechanisms of Action and Scientific Rationale — Curcuma aromatica

The pharmacological properties of Curcuma aromatica are determined by the presence of a complex of curcuminoids, sesquiterpenes (including ar-turmerone and α-turmerone), as well as auxiliary polyphenols and essential oils. These compounds exhibit activity through numerous targets at the molecular and cellular levels, covering both cytokine regulation and direct inhibition of enzymes of inflammation, oxidative stress, and cell proliferation.

One of the most confirmed mechanisms of action is the suppression of activation of the nuclear transcription factor NF-κB — a key regulator of inflammatory gene expression. Curcuminoids in the composition of C. aromatica suppress the phosphorylation of IκB kinase, which prevents the translocation of NF-κB into the nucleus and reduces the production of inflammatory mediators, including TNF-α, IL-1β, and IL-6. This effect is combined with inhibition of the MAPK signaling cascade, including ERK1/2 and p38, which limits cellular hyperproliferation, macrophage activation, and the synthesis of pro-inflammatory prostaglandins. 

References: https://pubmed.ncbi.nlm.nih.go...; https://www.sciencedirect.com/...

Curcuminoids of C. aromatica also affect the enzyme pathways of cyclooxygenase (COX-2) and lipoxygenase (5-LOX), reducing the synthesis of prostaglandins and leukotrienes involved in maintaining the inflammatory reaction. Direct inhibition of these enzymes is combined with antioxidant activity — suppression of oxidative stress by increasing the activity of antioxidant enzymes: superoxide dismutase, catalase, and glutathione peroxidase. Due to the ability to neutralize reactive oxygen and nitrogen species, the components of C. aromatica protect cellular structures from peroxide damage.

References: https://www.tandfonline.com/do...; https://www.sciencedirect.com/...

At the immunological level, curcuminoids have an immunosuppressive and modulating effect on cells of innate and adaptive immunity. They suppress the activation of Toll-like receptors (TLR4), reduce the expression of COX-2 and NO synthase in macrophages, inhibit IgE production in B lymphocytes, and regulate the differentiation of Th1/Th17 cells. This contributes to limiting hypercytokinemia and reducing the proliferation of activated immune cells.

References: https://www.ncbi.nlm.nih.gov/p...; https://pubmed.ncbi.nlm.nih.go...

The effect on the skin is due to the ability of curcuminoids to modulate the activity of epidermal growth factor (EGF), stimulate the expression of keratinocytes, and suppress the activity of tyrosinase — an enzyme involved in melanogenesis. These mechanisms underlie the depigmenting, reparative, and antiseptic effects. In addition, terpene components exhibit activity against microorganisms by damaging the cell wall and disrupting the membrane potential of bacteria and fungi.

References: https://www.sciencedirect.com/...; https://pubmed.ncbi.nlm.nih.go...

For the nervous system, inhibition of monoamine oxidase (MAO-A and MAO-B) has been recorded in Curcuma aromatica, as well as an influence on the receptor cascades of serotonin and dopamine, which may explain moderate neuromodulatory properties. Ar-turmerone and related sesquiterpenes participate in the activation of neural stem cells and reduce the expression of pro-inflammatory proteins in microglia, demonstrating neuroprotective potential.

References: https://www.ncbi.nlm.nih.gov/p...; https://pubmed.ncbi.nlm.nih.go...

In total, the mechanisms of action of Curcuma aromatica include modulation of transcription factors (NF-κB, STAT), enzyme systems (COX, LOX, MAO), receptors (TLR4, EGF, TRPV1), inflammatory mediators (cytokines, NO, PGE2), and regulation of immune cell activity. These mechanisms are supported by molecular, cellular, and preclinical studies registered in international databases.

Synergy — Curcuma aromatica

The pharmacological synergy of Curcuma aromatica with other natural compounds has been confirmed in a number of preclinical and experimental studies covering both systemic and local directions of action. The basis of synergistic effects is interaction with other phytochemical agents possessing similar or complementary mechanisms of action, especially along the lines of antioxidant, anti-inflammatory, antimicrobial, and immunomodulatory activity.

One of the well-documented examples is the potentiating interaction of curcuminoids of Curcuma aromatica with flavonoids — in particular, quercetin, rutin, and luteolin. The combined use of these compounds demonstrates an additive and in some cases super-additive effect in suppressing pro-inflammatory cytokines (TNF-α, IL-6) and inhibiting the NF-κB cascade. It has been established that flavonoids enhance the intracellular stability of curcuminoids, preventing their rapid metabolic destruction, thereby increasing their biological activity at the cellular level.

References: https://pubmed.ncbi.nlm.nih.go...; https://www.sciencedirect.com/...

Sesquiterpenes of Curcuma aromatica, including ar-turmerone, exhibit synergy with terpenoid components of essential oils of lavender, rosemary, and tea tree. The combined action of these substances leads to a more pronounced decrease in COX-2 expression and enhanced antibacterial activity against resistant forms of gram-positive and gram-negative bacteria. Such mixtures exhibit tissue-specific interaction at the level of the skin and mucous membranes, modulating the activity of epidermal receptors and enzyme systems.

References: https://www.tandfonline.com/do...; https://www.ncbi.nlm.nih.gov/p...

At the immune level, a synergistic interaction of Curcuma aromatica with β-glucans, saponins, and gallotannins has been recorded. These compounds, found in the roots of ginseng, echinacea, and astragalus, enhance the immunomodulatory effect of curcuminoids, exhibiting potentiation of the phagocytic activity of macrophages, normalization of the level of Th1/Th2 cytokines, and increased proliferation of T lymphocytes. The effect is systemic in nature and is due to cross-activation of the MAPK and JAK/STAT signaling cascades.

References: https://www.ncbi.nlm.nih.gov/p...; https://pubmed.ncbi.nlm.nih.go...

A positive modulating interaction of Curcuma aromatica with probiotic strains, such as Lactobacillus rhamnosus and Bifidobacterium longum, has also been confirmed. Curcuminoids support the growth and metabolic activity of the intestinal microflora, contribute to the improvement of the barrier function of the mucosa, and reduce the level of pro-inflammatory mediators in the intestinal wall. In response, the microflora increases the metabolic availability of curcuminoids through their microbial transformation into active forms.

References: https://www.sciencedirect.com/...; https://pubmed.ncbi.nlm.nih.go...

At the level of dermatotropic agents, Curcuma aromatica demonstrates synergy with the components of aloe vera, witch hazel, and Centella asiatica. This is manifested in the enhancement of regenerative activity and acceleration of epidermal repair with combined action on fibroblasts, stimulated through the PI3K/Akt pathways and VEGF expression. The nature of the synergy is additionally potentiating, localized within the skin.

References: https://www.sciencedirect.com/...; https://link.springer.com/arti...

Thus, the synergy of Curcuma aromatica is realized through multiple mechanisms at the cellular and tissue levels, including enzyme pathways, cytokine regulation, receptor interactions, and microbiome-dependent biotransformation, which makes this taxon a promising component of complex compositions of natural origin.

Geography of Use and Traditional Medicine — Curcuma aromatica

Curcuma aromatica is traditionally used in the folk and ritual medicine of South and Southeast Asia, predominantly in India, Sri Lanka, Nepal, Bangladesh, Thailand, Laos, and Myanmar. The plant has received the widest distribution in the Ayurvedic and Siddha schools of traditional medicine of the Indian subcontinent, where it is known as Vanya Haridra ("wild turmeric") and is considered one of the main plants that purify and protect the body. According to Ayurvedic sources, Curcuma aromatica is associated with the element of fire and is used in procedures aimed at balancing the Kapha and Pitta doshas.

In Thai folk medicine, the rhizomes of Curcuma aromatica are known under the name (khamin oi) and are widely used both in traditional recipes for external use and as part of herbal inhalation bags — prakop. Wraps with crushed fresh root and decoctions are used by women in the postpartum period, including in the practice of "yu fai" — thermal warming of the body. Among the peoples of Lanna and the Khmer, aromatic turmeric is traditionally part of ablutions, ritual baths, as well as ointments to protect the skin from external influences.

In the territory of Sri Lanka and South India, the plant was often used in home rituals of purification and blessing: the body of newborns, women before marriage, and patients after a long illness were rubbed with it. Often Curcuma aromatica was used together with sandalwood, fenugreek, neem, and rose water, especially in ritual pastes applied to the forehead, chest, and palms. In the magical-religious context, the plant was considered protective — its powder was sprinkled in the corners of the dwelling to prevent the influence of evil spirits, and burned with other resins in rites of purification of space.

In Tibetan medicine, mentions of Curcuma aromatica are found in the composition of complex mixtures known as "golden formulations." There it is used in the form of infusion and powder in combination with saffron, frankincense, and other aromatic resins. Use was accompanied by ritual offerings and meditative practices. Ethnographic information also confirms that in the mountainous regions of Nepal, the plant was part of smoking incense used in rites of appeal to spirits and in meditative ceremonies in monasteries.

In the culture of some groups of the peoples of northeast India, Curcuma aromatica was traditionally used as a cosmetic: women rubbed it on the face and body before sun exposure or important meetings. The plant was considered a symbol of purity and youth. Among the Munda and Santal tribes, the use of Curcuma aromatica powder was associated with rites of passage — puberty, marriage, and the end of mourning.

Historical mentions of Curcuma aromatica go back, according to Indian herbalists, to at least the 1st millennium AD. In Sanskrit and Pali texts, the plant was included in the composition of cleansing mixtures and remedies for external and ritual use. In the traditions of Java and Bali, the use of the plant in massage oils, cleansing mixtures, and body pastes has also been recorded. In these cultures, it was part of wedding cosmetic rites, often in combination with jasmine, lotus, and cananga oil.

Thus, the geography and depth of ethnomedical use of Curcuma aromatica covers a wide range of South and Southeast Asia, demonstrating the stable cultural and ritual value of the plant over the centuries.